Global Cell and Gene Therapy Supply Chain and Logistics Market Growth (Status and Outlook) 2024-2030
Cell and Gene Therapy Supply Chain and Logistics refer to the specialized processes and systems involved in managing the transportation, storage, and distribution of cell and gene therapy products. These therapies are often temperature-sensitive and require precise handling and monitoring.
The global Cell and Gene Therapy Supply Chain and Logistics market size is projected to grow from US$ million in 2023 to US$ million in 2030; it is expected to grow at a CAGR of % from 2024 to 2030.
LPI (LP Information)' newest research report, the “Cell and Gene Therapy Supply Chain and Logistics Industry Forecast” looks at past sales and reviews total world Cell and Gene Therapy Supply Chain and Logistics sales in 2023, providing a comprehensive analysis by region and market sector of projected Cell and Gene Therapy Supply Chain and Logistics sales for 2024 through 2030. With Cell and Gene Therapy Supply Chain and Logistics sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Cell and Gene Therapy Supply Chain and Logistics industry.
This Insight Report provides a comprehensive analysis of the global Cell and Gene Therapy Supply Chain and Logistics landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Cell and Gene Therapy Supply Chain and Logistics portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Cell and Gene Therapy Supply Chain and Logistics market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Cell and Gene Therapy Supply Chain and Logistics and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Cell and Gene Therapy Supply Chain and Logistics.
Cell and Gene Therapy Supply Chain and Logistics: With the rapid growth of cell and gene therapy development, there is a heightened focus on building robust and secure supply chains. Trends include the use of advanced tracking and monitoring technologies, cold chain logistics, and specialized packaging to ensure the safe and efficient delivery of these therapies to patients.
This report presents a comprehensive overview, market shares, and growth opportunities of Cell and Gene Therapy Supply Chain and Logistics market by product type, application, key players and key regions and countries.
Segmentation by type
Ordering and Scheduling Services
Sample Collection Services
Logistics Services
Post Treatment Follow-Up Services
Segmentation by application
Biobank
Cell Therapy Lab
Hospital
Research Institute
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Be The Match BioTherapies
Biocair
Marken
World Courier
MAK-SYSTEM
Cryoport
Brooks Life Sciences
Clarkston Consulting
Hypertrust Patient Data Care
Haemonetics
MasterControl
TraceLink
SAVSU Technologies
TrakCel
Title21 Health Solutions
sedApta Group
Vineti
Stafa Cellular Therapy
Thermo Fisher Scientific
McKesson
BioLife Solutions
Please note: The report will take approximately 2 business days to prepare and deliver.